Abstrak
Based on the Hospital Information System (HIS) in 2007, breast cancer is the top ranked diagnosed cancer in Indonesia. 1 In 2010, medical records of Dharmais Cancer Hospital revealed that, the breast cancer is the most common cancer suffered by women.
Estrogen receptor alpha (ERα) is associated with breast cancer and is overexpressed in cancer tissue.
2 Estradiol (E2) or 17-β estradiol, which is transduced through estrogen receptors, namely ERα, 3 is an agonist of the estrogen receptor ERα. Estradiol stimulation may affect the proliferation of breast cancer cells. 4 ERα is a protein with a weight of 66 kDa 5 which has the amino acid constituent active pocket consisting of Met343, Leu346, Leu349, Ala350, Glu353, Trp383, Leu384, Leu387, Met388, Leu391, Arg394, Phe404, Met421, Ile424, Phe425, Leu428, His524, Leu525, and Gly529. 6 Curcumol, curcumenol, and isocurcumenol is a sesquiterpene that is a constituent of the essential oil in white tumeric rhizomes. 7 In vivo studies of ethanol extract of white tumeric rhizomes showed it has chemopreventive effects on mammary gland cells in dose of 300 mg/kg. 8 In vitro studies of the curcumol in concentration of 50 μg/mL showed it has an activity as a growth inhibitors of cervical cancer HeLa cells (80%), breast cancer cells MCF-7 (74.57%), breast cancer cells MM231 (75%), and ovarian cancer cells OV-UL -2 (68.25%). Further research showed that curcumol was able to inhibit the synthesis of RNA in HeLa cells, MCF-7, and MM231. 9 Combination curcumenol and platicodin D showed inhibitory activity on the proliferation of breast cancer cells were better than each ingredient used alone. 10 Sitosterol is a phytosterol that is widely available in pumpkin seeds. 11 Pumpkin seed extract has been known to have several activities such as antidiabetic, antibacterial, anticancer, and antioxidant. Besides that, pumpkin seed oil is traditionally used as medicine in some countries such as China, Yugoslavia, Argentina, India, Mexico, Brazil, and the United States.
12 β-sitosterol acts as lowering cholesterol, 13 prostate-cancer, and breast-cancer. 14 In vitro studies of β-sitosterol in a concentration of 10 μM showed inhibitory activity on MCF-7 with percentage of inhibition of 39%. 15 This repot focus on in silico study of these compounds as inhibitors of estrogen receptor alpha (ERα) by the fact that there is no similar report has been published elsewhere.
This study explored the interaction of curcumol, curcumenol, isocurcumenol, and β-sitosterol against ERα through docking using ligand-based approach and the ligand used has been known having both in vitro and and in vivo biological activities.
METHODS

Tool
The hardware used for the calculations, molecular modeling and molecular docking include personal computer ACER ASPIRE 2920 with technical specifications of Intel Core 2 Duo CPU T5550 / 1.83 GHz, system operation 7 Ultimate 32-bit Windows, a hard disk capacity of 320 GB, and 2.0 GB of RAM. To verify, make sure that the AutoDockVina program used was valid, the model structure was overlayed with a ligand that had been crystallized using program HyperChem v8.0. Professional edition, redocking ligands had been crystallized into ERα binding pockets using the program AutoDock Vina and analysing of validation data.
Further, docking of curcumol, curcumenol, isocurcumenol, β-sitosterol, estradiol, and tamoxifen using AutoDock Vina program and last, interpretation of obtained data. All data has been carried out at least ten times with eight out of ten similar data. From figures and obatained data, we would be able to determine type of the binding and how strong its bound to ERα. figure 2 , and table 1 were obtained from preparation of ERα. Figure 1 showeds visualization of the results of the reduction of estrogen receptor alpha (ERα) of the form homodimer (chain A & B) (a) to form monomer (chain A) (b) using the program AutoDock Vina, Figure 2 shows pockets active of ERα using Q-SiteFinder programme. figure 3 and tables 2. 
RESULTS
Figures 1,
DISCUSSION Preparation ERα results were obtained from protein data bank
ERα were downloaded from the Protein Data Bank with PDB code: 1A52 which was the result of crystallization form of proteins with the estradiol ligand crystal with a value of 2.8 Å resolution. The receptor protein was a homodimer consisting of two units of the same monomers (chain ERα. A and B). Both monomer could be used as a ligand binding site because it had the same amino acid composition. However, to focus on the areas that will be docked receptors, then selected one monomer, the chain A. Reduction was conducted using the program chain SwissPDBViewer v4.01 ( Figure 1 ).
(b) To determine the amino acid residues of he active ERα pocket, it is necessary to analyze active pocket by recording amino acid residues bound with estradiol. Analyses were performed using the program Ligand Explorer Viewer and Q-SiteFinder ( Figure 2 ). Except to determine amino acid residue, Q-SiteFinder can also examine the volume of protein and active pocket volume. A chain volume was found 23488 A3 ERα, whereas active pocket volume was 561 A3. Active pocket volume used to predict whether a ligand will be able to fit into the receptor as a whole or only in a part. From the analysis of molecular properties, it was known that the six compounds (curcumol, curcumeno, isocurcumenol, β-sitosterol, estradiol and tamoxifen) have a greater volume than the volume of active ERα pocket, so it could be predicted that the six compounds as a whole would not fir into the ERα. But that does not mean that they can not produce biological activity, due to the fact that to activate a receptor (produce biological activity) does not have to enter the compound as a whole. In addition to volume, from Q-SiteFinder also obtained information about the coordinates of the minimum and maximum active pocket. Coordinates (x, y, z) minimum active pocket (site 1) located at 95, 15, and 96, while the maximum was located at coordinates 115, 35, and 113. The area between the minimum and maximum coordinates of the area was active. These coordinates was used to determine the grid to be used in the docking process.
Comparison of the amino acid residues of the active pocket ERα Ligand Explorer Viewer using Q-SiteFinder and can be seen in table 1. Table 1 showed the similarity of amino acid residues that were known by Ligand Explorer and Q-SiteFinder, which could be concluded that the amino acid residues were amino acid residues making up the active ERα pocket Number of amino acids in the Q-SiteFinder more numerous than Ligand Explorer Viewerwhich caused by a wider observation range. Its analysis was based on the principle of the interaction energy between macromolecules with a van der Waals loop to fi pockets that are considered the most favored binding by the ligand from the energy point of view (ie, pocket bonding interactions lowest energy). Whereas in the Ligand Explorer Viewer, amino acid residues crystals obtained from ligand-receptor interactions, thus narrower range observations. Therefore, the amino acid residues in the Q-SiteFinder clearer than Ligand Explorer Viewer.
Based on the analysis of ligand-receptor binding with Ligand Explorer Viewer, estradiol formed hydrogen bonds and hydrophobic interactions with ERα. Amino acids that formed hydrogen bonds with estradiol were Glu353, Arg394, and His524. While the amino acids that formed the hydrophobic interactions with the estradiol were Ala350, Leu387, Met388, Leu391, Phe404, Ile424, and Leu525. Preparation of ligands included the creation of 2D and 3D structure, geometry optimization, and analysis of the properties of 2D and 3D molekul. Structure created using 3D ChemBio program v.12.0.2 Free Trial. Figure 3 shows 2D-3D structures of curcumol, curcumenol, isocurcumenol, estradiol, β-sitosterol, and tamoxifen.
The optimized geometry of the 3D structure was done in order to obtain the most stable conformation with the lowest energy value (global minima). The compounds that have been optimized geometry was then analyzed by QSAR Properties nature in HyperChem program v8.0. Professional Edition. Results of analysis curcumol molecular properties, curcumenol, isocurcumenol, estradiol, β-sitosterol and tamoxifen are displayed in table 2.
As shown in table 2, the energy of the six compounds was negative, it indicated the six compounds were in a stable conformation, which was similar to the real situation in nature. To determine the feasibility of an oral drug candidate route, as a reference Lipinski'sRule of Five. 16 This rule describes the important properties of a molecule from pharmacokinetics point of view.
Value c log P (calculation log P) indicates the value of log P (lipophilicity) resulting from the calculation of computing. Value clog P is proportional to the value of log P. Value of log P of a compound to be developed as a drug route orally must meet the value required by Lipinski's Rule of Five i.e -2 < log P < 5. β-sitosterol had value c log P value is the greatest, thus this compound is predicted to have tendency to bind strongly to the cell membrane, thereby decreasing its bioavailability. 
Validation program AutoDock Vina
Validation aims to ensure that installed AutoDock Vina program had compatibility with used hardware as the hardware normally had different specifi Validation program AutoDock Vina done with overlay and redocking. The six compounds have mass more than 500 amu, corresponding to Lipinski's Rule of Five. The mass of a compound showed the ability to penetrate the membrane. If it is too large, then the compound will have difficulty to penetrate the membrane. Six compounds possessed volume were greater than the volume of the active pockets ERα (561 A 0 ), so that these six compounds were expected to be difficult to enter into the overall ERα.
Other molecular properties which determine the feasibility of a compound to be developed as a drug by oral route Lipinski' The overlay, validation can also be known through redocking, the process by which ligand crystal that has been isolated from a receptor in docking back into the receptor active pocket. Results redocking crystalline estradiol to ERα pocket is summarized in table 3.
Amino acid residues of redocking results were then compared with the results of Ligand Explorer Viewer. Comparison of results redocking amino acid residues with the Ligand Explorer Viewer shows AutoDock Vina redocking gave a slight shift in the position of the ligand. It shown from the slight differences in amino acid residues in the Ligand Explorer Viewer with redocking results, in which amino acid residues in the Ligand Explorer Viewer redocking more than the outcome. Shift in the position of the ligand was also evident from the number of hydrogen bonds, wherein the Ligand Explorer Viewer hydrogen bonds that formed four bonds, namely the amino acid Glu353 (two hydrogen bonds), Arg394, and His524 while redocking with AutoDock Vina resulted only produces three hydrogen bonds namely Glu353, Arg394, His524. So, in this case type of binding could be reproduced, but a shift in the position of the ligand. Docking results were able to reproduce the type of binding but showed ligand shift position was classifi as a near category, 18 therefore it can be concluded that in this study the results of using the docking software AutoDock Vina grouped under the category of "near".
Results of docking curcumol, curcumenol, isocurcumenol, β-sitosterol, estradiol, and tamoxifen using AutoDock program Vina and data interpretation Docking is a ligand placement technique into a pocket active receptor, which is a major step in computational studies to determine the level of interaction of a compound with the receptor. In this study, curcumol, curcumenol, isocurcumenol, and β-sitosterol was a tested ligand, estradiol as a natural ligand, whereas tamoxifen as a synthetic ligand. In this docking grid box made variations which is aimed to obtain optimum conditions for ligand interaction with reseptor. Grid box was an area where the ligand interacts with the active receptor pocket. Size of the grid box that will be tailored to the ligand in the docking, where the size should be larger than the volume of the ligand to be docked. This was done in order to obtain maximum ligandreceptor interactions. However, the size of the grid box should not too big because it was feared the ligand binds to the amino acids that are not constituent of active receptor pocket so the results were not accurate. Variations of grid box used were 15x15x15, 15x15x20, 15x20x15, 20x15x15, 20x15x20, and 20x20x15. From six grid box one of the best grid box, which was selected could produce optimal docking parameters. Retrieval grid box was best done by docking six compounds in each grid box variation with repetition as much as ten times and taken the three best. Grid was the best box 20x20x15, so the sixth compound docking was done at this grid box with ten repetitions and taken the three best. Results of docking curcumol, curcumenol, isocurcumenol, β-sitosterol, estradiol, and tamoxifen are shown in table 4. Table 4 showed some of the parameters used to analyze ligand-receptor interactions, such as the interaction energy (EI), inhibition constants (Ki), hydrogen bonds, and amino acid residues. Interaction energy (EI) is the energy required by a ligand to enter and interact with the receptor. EI of sixth compound was negative. It showed that the six compounds were able to interact easily with ERα. The smaller the value of EI, the easier entry and ligand binds to the receptor. EI value from the best was -10.7 kcal /mol, -8.5 kcal /mol, -8.3 kcal /mol, -8.0 kcal / mol, -7.9 kcal/mol, and -7.0 kcal/mol for estradiol, isocurcumenol, tamoxifen, curcumol, curcumenol, and β-sitosterol, respectively.
Inhibition constants (Ki) suggested the potential of a compound. The smaller the value of Ki value, the smaller of the concentration of compound which is required to interact with its receptor. Ki value is directly proportional to EI. Experimental Ki values in the range of 10 -12 to 10 -2 M (Bohm and Schneider, 2003) . Ki values from the best that was, 0,014 µM, 0,584 µM, 0,82 µM, 1,36 µM, 1,61µM and 7,35µM Curcumol interacted with ERα through hydrophobic interaction. Hydrophobic interactions were formed between the amino acids Met343 curcumol (3.6 Å), Leu346 (3.5 Å), Ala350 (3.7 to 3.9 Å), Leu387 (3.7 Å), Phe404 (3.5 to 3.9 Å), Met421 (3.7 Å), Leu428 (3.6 Å).
Curcumenol interacted with ERα through hydrogen bonds and hydrophobic interactions. Hydrogen bond was formed between the H atom of curcumenol with O atoms of the amino acids Leu346 (1.952 Å). In this case, curcumenol act as a donor and the amino acid leucine acts as a hydrogen bond acceptor. Hydrophobic interactions are formed between curcumeno and the amino acids of Ala350 (3.5 to 3.6 Å), Leu384 (3.3 Å), Leu387 (3.6 -3.7 Å), Met388 (3.5 Å), Leu391 (3.3 -3.8 Å), Phe404 (3.6 to 3.8 Å), and Leu428 (3.4 Å).
Isocurcumenol interacted with ERα through hydrophobic interactions. Isocurcumenol hydrophobic interactions formed between isocurcumenol and the amino acids of Leu349 (3.6 to 3.8 Å), Ala350 (3.7 Å), Leu384 (3.4 to 3.9 Å), Leu387 (3.5 to 3.9 Å), Met388 (3.5 to 3.7 Å), Phe404 (3.3 to 3.9 Å), and Leu525 (3.6 Å).
β-sitosterol interacted with ERα through hydrophobic interactions. Hydrophobic interactions formed between the β-sitosterol and the amino acids of Leu346 (3.2 to 3.9 Å), Thr347 (3.4 to 3.7 Å), Ala350 (3.3 to 3.8 Å), Leu354 (3.4 to 3 , 9A), Trp383 (3.0 to 3.9 Å), Leu384 (3.4 to 3.7 Å), Leu387 (3.4 to 3.7 Å), Met388 (3.5 to 3.7 Å), Phe404 (3.5 -3.8 Å), Ile424 (3.3 to 3.8 Å), and Leu525 (3.2 to 3.5 Å).
Interaction between the ligand comparison with
ERα is also noteworthy. Estradiol interacts with ERα through hydrogen bonds and hydrophobic interactions, whereas tamoxifen only hrough hydrophobic interaction. Hydrogen bonds were formed between atoms in estradiol estradiol with the O of Arg394 H atoms (2.191 Å) and the O atoms with H atoms His524 estradiol (2.196 Å) . In the formation of this hydrogen bond, estradiol acts as an acceptor, whereas amino acid (Arg394 and His524) acts as a donor. Estradiol interacts with hydrophobic amino acids Met388 (3.8 Å), Leu391 (3.6 -3.9 Å), and Leu525 (3.8 Å). Tamoxifen interacted with hydrophobic amino acids Leu346 (3.5 -3.8 Å), Ala350 (3.7 to 3.9 Å), Trp383 (3.2 to 3.7 Å), Phe404 (3.4-3.9 Å), Ile424 (3.4 Å), Phe425 (3.6 to 3.8 Å), and Leu428 (3.6-3.7 Å).
Presence of the above amino acids at the test compound in the docking with ERα as can be explain in Figure 4 . Figure 4 shows the results of docking between β-sitosterol with ERα. As shown, the amino acid residues of: Leu346, Thr347, Ala350, Asp351, Leu354, Trp383, Leu384, Leu387, Met388, Phe404, Ile424, Leu428, Leu525 were detected. Most likely the amino acids residues could inhibit ERα due to its steric hindrance effect. Overall results suggest natural products containing all four compounds have the potential to be used as medicine or adjuvant drug in anti-breast cancer therapy due to their activity against receptor ERα.
We have reported 20 that some compounds that are inhibitors activity against receptor ERα means that the compound can also act as an anti-infl drug that is caused by the cancer itself. This means that these compounds are predicted as antiinfl or as an adjuvant to cancer treatment drugs. The close relationship between infl and cancer has been described by Mantovani. 21 In conclusion, all the test compounds, namely curcumol, curcumenol, isocurcumenol of white tumeric (Curcuma zedoaria (Christm.) Roscoe), β-sitosterol from pumpkin seeds (Cucurbita pepo L.), and the comparator compounds, estradiol and tamoxifen can occupy active pocket ERα. Curcumenol and estradiol interacts with ERα through hydrogen bonds and hydrophobic interactions, whereas curcumol, isocurcumenol, β-sitosterol and tamoxifen interact through interactions in succession hydrophobic. Constanta of inhibition of the compound are 0.584 μM, 1.36 μM, and 1.61 μM for isocurcumenol, curcumol and curcumenol, respectively. Consequently, these predictions support that the natural products containing all four compounds have the potential to be used as medicine or adjuvant drug in anti-breast cancer therapy.
This study recommends that further research on toxicity data of the four compounds especially isocurcumenol as its has EI and Ki closer to tamoxifen for the search for breast anti-cancer drug.
